Physician profile
Aaron E Joiner
NPI 1255391587
$1,735.44
in general payments reported to CMS, 2019-2025
15 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $96.13 · 2022: $291 · 2023: $275 · 2024: $231 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $408.07 | 2024-2025 | Inspace, Pangea, Mako |
| Depuy Synthes Sales INC. | $363.46 | 2022-2025 | Na, Monovisc |
| Paragon 28, INC. | $264.44 | 2023-2025 | Portfolio, Phantom Fibula Nail |
| Alphatec Spine, INC | $152.51 | 2022 | |
| Zimmer Biomet Holdings, INC. | $130.21 | 2024 | Persona, Rosa |
| Abbvie INC. | $72.60 | 2021-2022 | |
| Heraeus Medical, LLC. | $66.81 | 2019 | |
| Kerecis Limited | $63.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $59.95 | 2019-2023 | Krystexxa |
| Globus Medical, INC. | $37.13 | 2023 | Hedron Ia |
| Smith+Nephew, INC. | $35.61 | 2019-2024 | Pico |
| Pacira Therapeutics, INC. | $29.72 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $22.72 | 2023 | Andexxa |
| Stimlabs LLC | $16.75 | 2025 | Corplex P |
| Heron Therapeutics, INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Joiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.